Polynovo | PNV - Ebitda



金融业
股票价格
AUD 0.89
资产
AUD 123.37M
现金及等价物
AUD 29.21M
销售成本
AUD 9.02M
流动资产
AUD 69.23M
流动负债
AUD 22.81M
债务
AUD 15.38M
EBIT
AUD 2.06M
EBITDA
AUD 3.89M
员工
301
EPS每股收益
AUD 0.01
股本和储备
AUD 83.14M
销售毛利
AUD 61.26M
债务利息支出
AUD 506K
贷款资金
AUD 15.39M
市值
AUD 614.31M
净收入
AUD 3K
营业费用
AUD 68.22M
营业利润
AUD 2.06M
普通股股本
AUD 690.84M
PE价格收益
58.54
税前利润
AUD 1.96M
销售收入
AUD 79.52M
销售和管理费用
AUD 17.05M
股票
AUD 8.97M
贸易债权人
AUD 4.9M
应收帐款人
AUD 24.21M


Ebitda 更改 日
Alcidion AUD 4.19M 365K 2025-12
Ansell USD 185.8M 7M 2025-12
Avita Medical AUD -5.56M 4.13M 2026-06
Cochlear AUD 306.4M 13.5M 2025-12
CSL USD 3.13B 1.17B 2025-12
Healius AUD 74.9M 40.3M 2025-06
Integral Diagnostics AUD 46.27M 3.52M 2024-06
Mayne Pharma AUD 20.9M 5.2M 2025-06
Nanosonics AUD 12.49M 1.13M 2025-12
Ramsay Health Care AUD 1.12B 10.6M 2025-12
ResMed USD 533.74M 29.91M 2026-09
Sonic Healthcare AUD 839.07M 51.09M 2024-12
Telix Pharmaceuticals AUD 76.49M 58.07M 2026-06